Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
About ABIM MOC
Medscape Education is proud to offer our members American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points through participation in selected CME activities.
Now, you can earn CME credit and ABIM MOC points at the same time from selected CME activities.
Activities are identified by the label CME / ABIM MOC next to the title.
Get started earning points toward your ABIM MOC today for FREE.
Verify Your ABIM ID
A onetime registration of your ABIM number and day/month of birth is required to establish the automatic transfer of ABIM MOC points.
View the status of your ID verification and accumulated points at any time on your Credit Tracker.
Confirmation of ABIM ID submission and point's verification may take up to 48 hours.
CME Credits
Earn CME credits for participating in and completing any CME activity on Medscape.org.
Activities on the Medscape Education web site are certified for AMA PRA Category 1 credit.
Participation in CME activities is recorded in your personal Credit Tracker.
ABIM MOC Points
Selected education activities are approved for ABIM MOC points and meet the criteria established by the American Board of Internal Medicine.
Points will be automatically submitted to the ABIM upon completion of the activity.
Medscape Education Infectious Diseases, September 2023
Did you know that cognitive behavioral therapy (CBT) is a validated treatment for irritable bowel syndrome (IBS)? Two experts discuss how it can be applied in practice.
What does the latest evidence say about how to use Bruton tyrosine kinase (BTK) inhibitors in the clinic for patients with chronic lymphocytic leukemia (CLL)?
How do we treat patients who need beyond third-line treatment for metastatic HER2-positive breast cancer? Drs Mahtani and Hamilton discuss how to manage these patients.
Do you know how to effectively integrate Bruton tyrosine kinase (BTK) inhibitors into the care of your patients with chronic lymphocytic leukemia (CLL)?
Are patients really taking their medications as prescribed? Experts discuss the realities of blood pressure control and where renal denervation may fit in the future.
Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?